Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-HBV-D HBcAg/HBeAg Antibody (E13#) (RVV11501)

Host species:Human
Isotype:IgG1
Applications:ELISA, SPR
Expression system:Mammalian Cells
Overview

Catalog No.

RVV11501

Expression system

Mammalian Cells

Species reactivity

Hepatitis B virus genotype D subtype adw (isolate United Kingdom/adyw/1979)(HBV-D) (P03147), Hepatitis B virus genotype D subtype ayw (isolate France/Tiollais/1979)(HBV-D)(P0C573)

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Capsid protein, Core antigen, Core protein, HBcAg, p21.5, C

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03147

Applications

ELISA, SPR

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

E13#

Data Image
  • SDS-PAGE
    SDS PAGE for HBV-D HBcAg/HBeAg Antibody (E13#)
  • SEC-HPLC
    The purity of this product is >95% as determined by SEC-HPLC.
References

Interpretation of HBV Serologies. PMID: 34593148

Evaluation of pregenomic HBV RNA in HBeAg-negative patients. PMID: 35699558

How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice? PMID: 23167981

Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses. PMID: 35163476

Letter to the editor: HBeAg expression suppressing/abolishing mutation elevated HBV DNA level in HBeAg-negative patients with chronic HBV infection. PMID: 35383987

Virological activity in treatment-naïve HBeAg-negative HBV-infected adult patients: A community-based study in Jiangsu, China. PMID: 32702877

Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: A community-based study. PMID: 28816955

HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation. PMID: 34292372

Is the function of the HBeAg really unknown? PMID: 31063442

Serum HBV RNA as a predictor of virological response in treatment-naive chronic HBeAg-positive HBV-infected patients with normal alanine aminotransferase. PMID: 36535012

HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B Virus. PMID: 35174107

Relationship between HBeAg and HBV DNA in patients with acute and persistent hepatitis B infection. PMID: 3773827

The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma. PMID: 37112837

HBeAg/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers. PMID: 19119537

The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. PMID: 27139263

Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers. PMID: 21352567

A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. PMID: 22749833

Hepatitis B virus e antigen and viral persistence. PMID: 34717215

[Induction of seroconversion in HBeAg expressing transgenic mice--comparison of murine model to HBV carriers]. PMID: 12442371

Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. PMID: 32805201

Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays. PMID: 23835030

Relationship between Maternal PBMC HBV cccDNA and HBV Serological Markers and its Effect on HBV Intrauterine Transmission. PMID: 31217048

A model to predict liver damage in patients with HBeAg-positive chronic HBV infection. PMID: 34091417

HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene. PMID: 29085029

HBV genotype B/C and response to lamivudine therapy: a systematic review. PMID: 24364035

Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas. PMID: 36851587

HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection. PMID: 24976702

A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice. PMID: 28426720

Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators. PMID: 27185623

Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT level. PMID: 15948237

Deacetylation of Notch1 by SIRT1 contributes to HBsAg- and HBeAg-mediated M2 macrophage polarization. PMID: 35234049

[Generation of a novel HBeAg transgenic mice using CRISPR/Cas9 technique]. PMID: 31640958

HBcrAg and pg RNA and the therapeutic effect in HBeAg-positive patients receiving anti-viral therapy, baseline serum HBV-RNA is a powerful predictor of response. PMID: 32277539

Identification of dihydroquinolizinone derivatives with cyclic ether moieties as new anti-HBV agents. PMID: 35700597

[The relationship of HBeAg status with HBV DNA loads, MELD scores in patients with acute-on-chronic hepatitis B liver failure during terminal phases]. PMID: 22919755

Can we stop nucleoside analogues before HBsAg loss? PMID: 30803099

Inhibition of HBsAg and HBeAg expression by shRNA expressing vectors targeting HBV s and e gene. PMID: 21351686

Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests. PMID: 12118438

[Clinical significance and natural history of "HBeAg negativity" in patients with chronic HBV infection]. PMID: 16804337

Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PMID: 21494570

HBeAg(+) and sex ratio of offspring: evidence form Taiwan's three million newborns. PMID: 22431495

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HBV-D HBcAg/HBeAg Antibody (E13#) [RVV11501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only